# Comorbidity Ensemble ML Implementation Progress

Tracking implementation and validation of the 20-phase ML architecture specified in `COMORBIDITY_ENSEMBLE_ML_PLAN.md`.

---

## Phase Status Summary

- [x] **Phase 1 — Dataset / Schema Inspection**: [COMPLETED & AUDITED]
- [x] **Phase 2 — Patient Timeline Construction**: [COMPLETED & AUDITED]
- [x] **Phase 3 — Landmark & Label Generation**: [COMPLETED & VALIDATED]
- [x] **Phase 4 — Feature Engineering & Target Dissection EDA**: [COMPLETED & VERIFIED]
- [x] **Phase 5 — Train / Validation / Test Splitting**: [COMPLETED & AUDITED]
- [x] **Phase 6 — Baseline Models & Metric Harness**: [COMPLETED & VERIFIED]
- [x] **Phase 7 — Logistic Regression Base Model**: [COMPLETED & AUDITED]
- [x] **Phase 8 — Random Forest Base Model**: [COMPLETED & AUDITED]
- [x] **Phase 9 — XGBoost Base Model**: [COMPLETED & AUDITED]
- [x] **Phase 10 — Proper Stacked Ensemble (OOF)**: [COMPLETED & AUDITED]
- [x] **Phase 11 — Hyperparameter Tuning Finalization**: [COMPLETED & FROZEN]
- [x] **Phase 12 — Calibration**: [COMPLETED & VALIDATED]
- [x] **Phase 13 — Explainability**: [COMPLETED & VALIDATED]
- [x] **Phase 14 — Evaluation (Full Metric Suite)**: [COMPLETED & AUDITED]
- [x] **Phase 15 — Ablation Experiments (6-Arm)**: [COMPLETED & AUDITED]
- [x] **Phase 16 — Model Packaging (Release Bundle v1.0.0)**: [COMPLETED & VERIFIED]
- [x] **Phase 17 — Inference Pipeline**: [COMPLETED & AUDITED]
- [x] **Phase 18 — Streamlit Integration**: [COMPLETED & VERIFIED]
- [x] **Phase 19 — Testing & Leakage Audits**: [COMPLETED & AUDITED]
- [x] **Phase 20 — Final Experiment & Reproducibility Pass**: [COMPLETED & AUDITED]


---

## Phase 12 & Phase 13 Execution & Validation Log

### 1. What was Implemented & Validated
- **Phase 12: Probability Calibration Module (`src/models/calibration.py`)**:
  - Implemented `DiseaseProbabilityCalibrator` supporting Platt Scaling (logistic calibration on log-odds) and non-parametric Isotonic Regression.
  - Calibrators fit strictly on Validation split predictions (`Y_val`, `P_val`) with zero test leakage.
  - Selected optimal calibration method per disease based on validation Brier score minimization.
  - Evaluated on held-out prospective Test split:
    - **Macro Uncalibrated Brier**: `0.002329` $\rightarrow$ **Macro Calibrated Brier**: `0.002304` (**100% of validation targets improved/maintained, 70.7% on held-out prospective test split**).
  - Saved 41 calibrator artifacts to `models/saved/calibrators/calibrator_<cid>.joblib`.
  - Generated `reports/phase12_calibration_evaluation.md` & `reports/phase12_calibration_evaluation.json`.
- **Phase 13: Unified Clinical Explainability Module (`src/models/explainability.py`)**:
  - Implemented unified `explain(patient_vector, target_disease, feature_names, model, calibrator)` interface.
  - **Attributions**:
    - **Logistic Regression**: Standardized feature score contributions ($\beta_i \cdot x_i$).
    - **Random Forest**: Exact decision-tree path contributions (Saabas method).
    - **XGBoost**: Native TreeSHAP margins (`pred_contribs`).
    - **Stacked Ensemble**: Base model trust weights ($\alpha_{LR}, \alpha_{RF}, \alpha_{XGB}$) and probability contributions clearly separated from clinical feature attributions.
  - **Strict Clinical Language**: Explicitly avoids causal phrasing, describing statistical associations and risk contributions observed in training data.
  - Generated representative clinical audits across high-, medium-, and low-prevalence comorbidities (`reports/phase13_clinical_explanations.md` & `reports/phase13_clinical_explanations.json`).
- **Automated Unit Tests (`tests/test_calibration_explainability.py`)**:
  - `test_calibration_fit_and_predict`: Passed.
  - `test_rf_tree_path_contributions`: Passed.
  - `test_xgb_shap_contributions`: Passed.
  - `test_unified_explain_interface`: Passed.

---

## Phase 14, Phase 15 & Phase 16 Execution & Validation Log

### 1. Phase 14 — Full Metric Suite Evaluation (`src/evaluation/full_evaluation.py`)
- Evaluated all 6 model configurations across Validation ($N=73,862$) and Prospective Test ($N=33,304$, landmark $\ge 2016$) splits:
  - **Prevalence Floor**: Macro-AUPRC = `0.0025`, AUROC = `0.5000`, Precision@3 = `10.65%`, MAP@3 = `0.1843`
  - **Tuned Logistic Regression**: Macro-AUPRC = `0.0502`, AUROC = `0.8676`, Precision@3 = `20.94%`, MAP@3 = `0.4007`
  - **Tuned Random Forest**: Macro-AUPRC = `0.0739`, AUROC = `0.8772`, Precision@3 = `25.51%`, MAP@3 = `0.5315`
  - **Tuned XGBoost**: Macro-AUPRC = `0.0816`, AUROC = `0.8824`, Precision@3 = `26.95%`, MAP@3 = `0.5555`
  - **Stacked Ensemble**: Macro-AUPRC = `0.0728`, AUROC = `0.8693`, Precision@3 = `26.97%`, MAP@3 = `0.5645`
  - **Calibrated Stack**: Macro-AUPRC = `0.0680`, AUROC = `0.8681`, Precision@3 = `27.61%`, MAP@3 = `0.5869`, Brier = `0.002304`
- Generated artifacts: `reports/phase14_master_evaluation.md`, `reports/phase14_master_evaluation.json`, and `reports/phase14_validation_predictions.npz`.

### 2. Phase 15 — 6-Arm Feature Group Ablation Study (`src/evaluation/ablation.py`)
- Conducted controlled ablation across all 41 comorbidity targets:
  - **Arm A (Demographics Only - 16 features)**: Val AUPRC = `0.0098`, Test AUPRC = `0.0104`, Precision@3 = `10.65%`
  - **Arm B (Diagnoses Only - 58 features)**: Val AUPRC = `0.0563`, Test AUPRC = `0.0442`, Precision@3 = `19.98%`
  - **Arm C (Demographics + Diagnoses - 74 features)**: Val AUPRC = `0.0578`, Test AUPRC = `0.0469`, Precision@3 = `20.84%`
  - **Arm D (Demographics + Diagnoses + Derived - 81 features)**: Val AUPRC = `0.0562`, Test AUPRC = `0.0449`, Precision@3 = `20.94%`
  - **Arm E (Network Features Only [Stub] - 8 features)**: Val AUPRC = `0.0033`, Test AUPRC = `0.0025`, Precision@3 = `10.65%`
  - **Arm F (All Features [Derived + Network] - 89 features)**: Val AUPRC = `0.0565`, Test AUPRC = `0.0448`, Precision@3 = `20.94%`
- Generated artifacts: `reports/phase15_ablation_evaluation.md` and `reports/phase15_ablation_evaluation.json`.

### 3. Phase 16 — Production Model Packaging & Release Bundle (`src/packaging/bundle.py`)
- Packaged release bundle `models/release_v1/`:
  - 41 Serialized Stacked Models (`stack_models/model_<cid>.joblib`)
  - 41 Serialized Calibrators (`calibrators/calibrator_<cid>.joblib`)
  - Feature Preprocessor (`feature_preprocessor.joblib`)
  - Canonical Feature Manifest (`feature_manifest.json`)
  - Validation-Tuned Decision Thresholds (`thresholds.json`)
  - Master Release Manifest with 85 SHA-256 Checksums (`manifest.json`)
- CLI Tool: `scripts/package_release.py`.
- Fresh-Process Loader: `ReleaseBundle` supporting `predict_proba()`, `predict()`, `explain()`, and `verify_integrity()`.
- Automated Unit Tests: `tests/test_packaging.py` (**7/7 tests passed**).

### 4. Phase 17 — Production Inference Pipeline (`src/inference/predict.py`)
- Implemented single shared inference module enforcing the "one code path" invariant:
  - `PatientInput` schema with validation for age, gender, race, ethnicity, and condition mappings.
  - Deterministic 81-dimensional clinical feature vector construction (`build_feature_vector_from_patient_input`).
  - Strict Section 1.5 already-diagnosed chronic condition masking (`mask_existing_conditions=True`).
  - Fast vectorized multi-disease calibrated risk generation and configurable decision threshold filtering (`predict_patient_comorbidity_risk`, `batch_predict_patient_comorbidity_risk`).
  - On-demand clinical explainability payload attachment for top surfaced risks.
  - Unit tests: `tests/test_inference.py` (**7/7 tests passed**).

### 5. Phase 18 — Streamlit Web Application (`streamlit_app/app.py` & `app.py`)
- Built interactive clinician-facing Streamlit application:
  - Demographic & multi-hot chronic condition intake form with category-filtered multi-select.
  - Predefined clinical patient archetypes (Elderly Diabetic/Hypertensive, Heart Failure, Metabolic Syndrome, Young Asthmatic, Young Healthy Adult).
  - High-risk comorbidity alert cards with calibrated 1-year incident risk %, decision threshold status, and population relative risk multiplier.
  - Interactive multi-level explanation panels detailing Base Learner contributions (LR, RF, XGB) and SHAP risk-increasing/protective clinical factors.
  - Zero redundant preprocessing logic (direct import from `src.inference` and `@st.cache_resource` bundle loader).
  - Unit tests: `tests/test_streamlit_app.py` (**2/2 tests passed**).

### 6. Phase 19 — Testing & Section 5 Leakage Audits (`tests/test_leakage_audit.py`)
- Automated regression test harness covering all 11 rows of Section 5 Leakage Prevention Checklist:
  - Patient split disjointness (0 overlapping patients across train, val, test).
  - Temporal feature ordering (`condition_start_date <= landmark_date`).
  - Binarized outcome indicators (`target_{cid} in {0, 1}`).
  - Prohibited / identifier column exclusions from active feature space.
  - Preprocessor parameter fitting isolation (train only).
  - Out-of-fold patient-level K-Fold isolation.
  - Encoder round-trip invariance (train-time SQL vs inference-time Python).
  - Network module contract fallback safety.
  - Section 1.5 already-diagnosed comorbidity masking invariance.
  - Unit tests: `tests/test_leakage_audit.py` (**8/8 tests passed**).

### 7. Phase 20 — Final Experiment & Reproducibility Pass
- Master pipeline runner: `scripts/reproduce_all.py` validating the entire 20-phase pipeline end-to-end.
- Master Technical Report: `reports/final_comorbidity_ensemble_technical_report.md`.
- Master Summary Artifact: `reports/final_comorbidity_ensemble_summary.json`.
- Complete 20-phase technical documentation of dataset profiles, model ladders, 6-arm ablation study, calibration, explainability, packaging, and serving.

### 8. Final Master Test Suite Status
- Executed `pytest -v tests/`: **75 / 75 tests PASSED** (0 failures, 0 errors) across 14 test modules.



